Arbor Rapha Capital Bioholdings Corp I - Units (1 Ord Share Class A & 1/3 War)
$10.17 - 29-10-2024 4 p.m. ET
Company Profile
RCM is an investment management firm located in Miami, Florida focused on identifying and managing strategic investments in early stage, non-public biotechnology companies, with a strategy of identifying and growing revolutionary and disruptive ideas in medicine, healthcare, and biotechnology before others can see their value. RCM executes its investment strategy by making equity and convertible debt investments in privately held companies that RCM believes have developed a transformative product, technology, or process that will drive long-term value creation for shareholders. RCM’s portfolio companies currently focus on a wide range of targets, including immunotherapies, medical devices, ocular diseases, genome editing, cell and gene therapy and bioprinting.